Allison Makovec

Feb 27, 2024 | nature.com | Nicholas A. Zorko |Yousef Zakharia |Vivek Narayan |Elisabeth I. Heath |Allison Makovec

AbstractNatural killer (NK) cells are non-antigen specific innate immune cells that can be redirected to targets of interest using multiple strategies, although none are currently FDA-approved. We sought to evaluate NK cell infiltration into tumors to develop an improved understanding of which histologies may be most amenable to NK cell-based therapies currently in the developmental pipeline.